202 related articles for article (PubMed ID: 29869821)
21. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
[TBL] [Abstract][Full Text] [Related]
22. Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.
Jian Y; Wang M; Zhang Y; Ou R; Zhu Z; Ou Y; Chen X; Liang X; Ding Y; Song L; Xu X; Liao W
Cancer Lett; 2018 Aug; 428():1-11. PubMed ID: 29660380
[TBL] [Abstract][Full Text] [Related]
23. MYC-associated protein X binding with the variant rs72780850 in RNA helicase DEAD box 1 for susceptibility to neuroblastoma.
Jin Y; Shi J; Wang H; Lu J; Chen C; Yu Y; Wang Y; Yang Y; Ren D; Zeng Q; Ni X; Guo Y
Sci China Life Sci; 2021 Jun; 64(6):991-999. PubMed ID: 32915406
[TBL] [Abstract][Full Text] [Related]
24. LGR5 positivity defines stem-like cells in colorectal cancer.
Hirsch D; Barker N; McNeil N; Hu Y; Camps J; McKinnon K; Clevers H; Ried T; Gaiser T
Carcinogenesis; 2014 Apr; 35(4):849-58. PubMed ID: 24282287
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo.
Lin F; Wang R; Shen JJ; Wang X; Gao P; Dong K; Zhang HZ
Cancer Biol Ther; 2008 Oct; 7(10):1669-76. PubMed ID: 18769115
[TBL] [Abstract][Full Text] [Related]
26. High Expression of Stem Cell-Related Genes in Polyps with Villous Features and High-Grade Dysplasia Support Malignant Phenotype and Colorectal Carcinogenesis.
Sahin I; Gündoğdu B; Ceylan AC; Erdem HB; Tatar A
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2429-2435. PubMed ID: 34452555
[TBL] [Abstract][Full Text] [Related]
27. A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.
Lin MH; Sivakumaran H; Jones A; Li D; Harper C; Wei T; Jin H; Rustanti L; Meunier FA; Spann K; Harrich D
Retrovirology; 2014 Dec; 11():121. PubMed ID: 25496916
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.
Uchida H; Yamazaki K; Fukuma M; Yamada T; Hayashida T; Hasegawa H; Kitajima M; Kitagawa Y; Sakamoto M
Cancer Sci; 2010 Jul; 101(7):1731-7. PubMed ID: 20384634
[TBL] [Abstract][Full Text] [Related]
29. Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression.
Jang BG; Kim HS; Chang WY; Bae JM; Kim WH; Kang GH
Am J Pathol; 2018 Oct; 188(10):2236-2250. PubMed ID: 30036518
[TBL] [Abstract][Full Text] [Related]
30. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
31. Long interspersed nucleotide acid element-1 ORF-1 protein promotes proliferation and invasion of human colorectal cancer LoVo cells through enhancing ETS-1 activity.
Li MY; Zhu M; Feng F; Cai FY; Fan KC; Jiang H; Wang ZQ; Linghu EQ
Genet Mol Res; 2014 Apr; 13(3):6981-94. PubMed ID: 24782214
[TBL] [Abstract][Full Text] [Related]
32. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
33. The DEAD-Box RNA Helicase DDX1 Interacts with the Viral Protein 3D and Inhibits Foot-and-Mouth Disease Virus Replication.
Xue Q; Liu H; Zeng Q; Zheng H; Xue Q; Cai X
Virol Sin; 2019 Dec; 34(6):610-617. PubMed ID: 31359346
[TBL] [Abstract][Full Text] [Related]
34. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
35. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
[TBL] [Abstract][Full Text] [Related]
36. MUC1-C drives stemness in progression of colitis to colorectal cancer.
Li W; Zhang N; Jin C; Long MD; Rajabi H; Yasumizu Y; Fushimi A; Yamashita N; Hagiwara M; Zheng R; Wang J; Kui L; Singh H; Kharbanda S; Hu Q; Liu S; Kufe D
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427590
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody-Drug Conjugates.
Azhdarinia A; Voss J; Ghosh SC; Simien JA; Hernandez Vargas S; Cui J; Yu WA; Liu Q; Carmon KS
Mol Pharm; 2018 Jun; 15(6):2448-2454. PubMed ID: 29718672
[TBL] [Abstract][Full Text] [Related]
38. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
39. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
[TBL] [Abstract][Full Text] [Related]
40. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
Lu J; Zhang L; Zhou H; Du Z; Zhang G
Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
